High expression of ERp57 is associated with poor overall survival (OS) and high recurrence-free survival rates in adenocarcinoma patients, and it is overexpressed in 73% of cervical malignancies, particularly adenocarcinoma. This evidence concerns the gene PDIA3 and adenocarcinoma.